Preferences help
enabled [disable] Abstract
Number of results
2017 | 64 | 1 | 85-92
Article title

Characterization of mAb6-9-1 monoclonal antibody against hemagglutinin of avian influenza virus H5N1 and its engineered derivative, single-chain variable fragment antibody

Title variants
Languages of publication
Hemagglutinin (HA), as a major surface antigen of influenza virus, is widely used as a target for production of neutralizing antibodies. Monoclonal antibody, mAb6-9-1, directed against HA of highly pathogenic avian influenza virus A/swan/Poland/305-135V08/2006(H5N1) was purified from mouse hybridoma cells culture and characterized. The antigenic specificity of mAb6-9-1 was verified by testing its cross-reactivity with several variants of HA. The mimotopes recognized by mAb6-9-1 were selected from two types of phage display peptide libraries. The comparative structural model of the HA variant used for antibody generation was developed to further facilitate epitope mapping. Based on the sequences of the affinity- selected polypeptides and the structural model of HA the epitope was located to the region near the receptor binding site (RBS). Such localization of the epitope recognized by mAb6-9-1 is in concordance with its moderate hemagglutination inhibiting activity and its antigenic specificity. Additionally, total RNA isolated from the hybridoma cell line secreting mAb6-9-1 was used for obtaining two variants of cDNA encoding recombinant single-chain variable fragment (scFv) antibody. To ensure high production level and solubility in bacterial expression system, the scFv fragments were produced as chimeric proteins in fusion with thioredoxin or displayed on a phage surface after cloning into the phagemid vector. Specificity and affinity of the recombinant soluble and phage-bound scFv were assayed by suitable variants of ELISA test. The observed differences in specificity were discussed.
Physical description
  • Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland
  • Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland
  • Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland
  • Interdisciplinary Centre for Mathematical and Computational Modelling, Warsaw University, Warsaw, Poland
  • Institute of Biotechnology and Antibiotics, Warsaw, Poland
  • Institute of Biotechnology and Antibiotics, Warsaw, Poland
  • Department of Recombinant Vaccines, Intercollegiate Faculty of Biotechnology, University of Gdansk and Medical University of Gdansk, Gdańsk, Poland
  • Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland
  • Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland
  • Al-Majhdi F (2007) Structure of the sialic acid binding site in influenza A virus: hemagglutinin. J Biol Sci 7: 113-122
  • Ascione A, Capecchi B, Campitelli L, Imperiale V, Flego M, Zamboni S, Gellini M, Alberini I, Pittiglio E, Donatelli I, Temperton NJ, Cianfriglia M (2009) Human monoclonal antibodies in single chain fragment variable format with potent neutralization activity against influenza virus H5N1. Antiviral Res 83: 238-244. doi: 10.1016/j.antiviral.2009.05.005.
  • Bublil EM, Freund NT, Mayrose I, Penn O, Roitburd-Berman A, Rubinstein ND, Pupko T, Gershoni JM (2007) Stepwise prediction of conformational discontinuous B-Cell Epitopes using the mapitope algorithm. Proteins 68: 294-304. doi: 10.1002/prot.21387.
  • Cao Y, Marks JD, Huang Q, Rudnick SI, Xiong C, Hittelman WN, Wen X, Marks JW, Cheung LH, Boland K, Li C, Adams GP, Rosenblum MG (2012a) Single-chain antibody-based immunotoxins targeting Her2/neu: design optimization and impact of affinity on antitumor efficacy and off-target toxicity. Mol Cancer Ther 11: 143-153. doi: 10.1158/1535-7163.MCT-11-0519.
  • Cao Z, Meng J, Li X, Wu R, Huang Y, He Y (2012b) The epitope and neutralization mechanism of AVFluIgG01, a broad-reactive human monoclonal antibody against H5N1 influenza virus. Plos One 7. doi: 10.1371/journal.pone.0038126.
  • Choo AB, Dunn RD, Broady KW, Raison RL (2002) Soluble expression of a functional recombinant cytolytic immunotoxin in insect cells. Protein Expr Purif 24: 338-347. doi: 10.1006/prep.2001.1589.
  • Dobhal S, Chaudhary VK, Singh A, Pandey D, Kumar A, Agrawal S (2013) Expression of recombinant antibody (single chain antibody fragment) in transgenic plant Nicotiana tabacum cv. Xanthi. Mol Biol Rep 40: 7027-7037. doi: 10.1007/s11033-013-2822-x.
  • Dorsam H, Braunagel M, Kleist C, Moynet D, Welschof M (2002) Screening of phage displayed antibody libraries. The Protein Protocols Handbook 1073-1082. MEDLINE
  • Du L, Jin L, Zhao G, Sun S, Li J, Yu H, Li Y, Zheng BJ, Liddington RC, Zhou Y, Jiang S (2013) Identification and structural characterization of a broadly neutralizing antibody targeting a novel conserved epitope on the influenza virus H5N1 hemagglutinin. J Virol 87: 2215-2225.
  • Ho M, Nagata S, Pastan I (2006) Isolation of anti-CD22 Fv with high affinity by Fv display on human cells. Proc Natl Acad Sci U S A 103: 9637-9642.
  • Jarocka U, Sawicka R, Gora-Sochacka A, Sirko A, Dehaen W, Radecki J, Radecka H (2016) An electrochemical immunosensor based on a4,4-thiobisbenzenethiol self-assembled monolayer for the detectionof hemagglutinin from avian influenza virus H5N1. Sensors and Acttuators B Chemical 228: 25-30
  • Jarocka U, Sawicka R, Góra-Sochacka A, Sirko A, Zagórski-Ostoja W, Radecki J, Radecka H (2014) An immunosensor based on antibody binding fragments attached to gold nanoparticles for the detection of peptides derived from avian influenza hemagglutinin H5. Sensors (Basel) 14: 15714-15728. doi: 10.3390/s140915714.
  • Jurado P, de Lorenzo V, Fernandez LA (2006) Thioredoxin fusions increase folding of single chain Fv antibodies in the cytoplasm of Escherichia coli: Evidence that chaperone activity is the prime effect of thioredoxin. J Mol Biol 357: 49-61. doi: 10.1016/j.jmb.2005.12.058.
  • Kaku Y, Noguchi A, Okutani A, Inoue S, Tanabayashi K, Yamamoto Y, Hotta A, Suzuki M, Sugiura N, Yamada A (2012) Altered specificity of single-chain antibody fragments bound to pandemic H1N1-2009 influenza virus after conversion of the phage-bound to the soluble form. BMC Res Notes 5: 483. doi: 10.1186/1756-0500-5-483.
  • Kalenik B, Sawicka R, Góra-Sochacka A, Sirko A (2014) Influenza prevention and treatment by passive immunization. Acta Biochim Pol 61: 573-587.
  • Kyte J, Doolittle RF (1982) A simple method for displaying the hydropathic character of a protein. J Mol Biol 157: 105-132. 10.1016/0022-2836(82)90515-0.
  • Ladiges W, Osman GE (2001) Molecular characterization of immunoglobulin genes. In Basic Methods in Antibody Production and Characterization. Howard GC & Bethell D eds, pp 169-192: CRC Press LLC. MEDLINE
  • Li Y, Zhang X, Xu Q, Fu Q, Zhu Y, Chen S, Peng D, Liu X (2013) Characterisation and haemagglutinin gene epitope mapping of a variant strain of H5N1 subtype avian influenza virus. Vet Microbiol 162: 614-622.
  • Mayrose I, Penn O, Erez E, Rubinstein ND, Shlomi T, Freund NT, Bublil EM, Ruppin E, Sharan R, Gershoni JM, Martz E, Pupko T (2007a) Pepitope: epitope mapping from affinity-selected peptides. Bioinformatics 23: 3244-3246. doi: 10.1093/bioinformatics/btm493.
  • Mayrose I, Shlomi T, Rubinstein ND, Gershoni JM, Ruppin E, Sharan R, Pupko T (2007b) Epitope mapping using combinatorial phage-display libraries: a graph-based algorithm. Nucleic Acids Research 35: 69-78. doi: 10.1093/nar/gkl975.
  • Meng EC, Pettersen EF, Couch GS, Huang CC, Ferrin TE (2006) Tools for integrated sequence-structure analysis with UCSF Chimera. Bmc Bioinformatics 7. doi: 10.1186/1471-2105-7-339.
  • Oriuchi N, Higuchi T, Hanaoka H, Iida Y, Endo K (2005) Current status of cancer therapy with radiolabeled monoclonal antibody. Ann Nucl Med 19: 355-365.
  • Peng Y, Zou Y, Li H, Li K, Jiang T (2014) Inferring the antigenic epitopes for highly pathogenic avian influenza H5N1 viruses. Vaccine 32: 671-676. doi: 10.1016/j.vaccine.2013.12.005.
  • Rouet R, Lowe D, Dudgeon K, Roome B, Schofield P, Langley D, Andrews J, Whitfeld P, Jermutus L, Christ D (2012) Expression of high-affinity human antibody fragments in bacteria. Nature Protocols 7: 364-373. doi: 10.1038/nprot.2011.448.
  • Sali A, Blundell TL (1993) Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234: 779-815. doi: 10.1006/jmbi.1993.1626.
  • Shepelyakovskaya AO, Laman AG, Lomonosova AV, Fursova KK, Savinov GV, Vertiev YV, Brovko FA, Grishin EV (2011) Effect of the format of antibodies on their specificity. Mol Immunol 49: 433-440. doi: 10.1016/j.molimm.2011.09.017.
  • Smith GJD, Donis RO, Working WOFHNE (2012) Continued evolution of highly pathogenic avian influenza A (H5N1): updated nomenclature. Influenza Other Respir Viruses 6: 1-5. doi: 10.1111/j.1750-2659.2011.00298.x.
  • Smith GJD, Donis RO, World Health Organization W (2015) Nomenclature updates resulting from the evolution of avian influenza A(H5) virus clades, 2.2.1, and 2.3.4 during 2013-2014. Influenza Other Respir Viruses 9: 271-276. doi: 10.1111/irv.12324.
  • Sonoda H, Kumada Y, Katsuda T, Yamaji H (2010) Functional expression of single-chain Fv antibody in the cytoplasm of Escherichia coli by thioredoxin fusion and co-expression of molecular chaperones. Protein Expr Purif 70: 248-253. doi: 10.1016/j.pep.2009.11.003.
  • Stachyra A, Gora-Sochacka A, Sawicka R, Florys K, Saczynska V, Olszewska M, Pikula A, Smietanka K, Minta Z, Szewczyk B, Zagorski W, Sirko A (2014) Highly immunogenic prime-boost DNA vaccination protects chickens against challenge with homologous and heterologous H5N1 virus. Trials Vaccinol 3: 40-46
  • Stachyra A, Redkiewicz P, Kosson P, Protasiuk A, Góra-Sochacka A, Kudla G, Sirko A (2016) Codon optimization of antigen coding sequences improves the immune potential of DNA vaccines against avian influenza virus H5N1 in mice and chickens. Virol J 13: 143. doi: 10.1186/s12985-016-0599-y.
  • Szewczyk B, Bienkowska-Szewczyk K, Krol E (2014) Introduction to molecular biology of influenza A viruses. Acta Biochim Pol 61: 397-401.
  • Tan Y, Ng Q, Jia Q, Kwang J, He F (2015) A novel humanized antibody neutralizes H5N1 influenza virus via two different mechanisms. J Virol 89: 3712-3722. doi: 10.1128/JVI.03014-14.
  • Toleikis L, Frenzel A (2012) Cloning single-chain antibody fragments (ScFv) from hyrbidoma cells. Methods Mol Biol 907: 59-71.
  • Velkov T, Ong C, Baker MA, Kim H, Li J, Nation RL, Huang JX, Cooper MA, Rockman S (2013) The antigenic architecture of the hemagglutinin of influenza H5N1 viruses. Mol Immunol 56: 705-719. doi: 10.1016/j.molimm.2013.07.010.
  • Wu R, Li X, Leung HC, Cao Z, Qiu Z, Zhou Y, Zheng BJ, He Y (2014) A novel neutralizing antibody against diverse clades of H5N1 influenza virus and its mutants capable of airborne transmission. Antiviral Res 106: 13-23. doi: 10.1016/j.antiviral.2014.03.005.
  • Zhang X, Qi X, Zhang Q, Zeng X, Shi Z, Jin Q, Zhan F, Xu Y, Liu Z, Feng Z, Jiao Y (2013) Human 4F5 single-chain Fv antibody recognizing a conserved HA1 epitope has broad neutralizing potency against H5N1 influenza A viruses of different clades. Antiviral Res 99: 91-99. doi: 10.1016/j.antiviral.2013.05.001.
  • Zuo T, Sun J, Wang G, Jiang L, Zuo Y, Li D, Shi X, Liu X, Fan S, Ren H, Hu H, Sun L, Zhou B, Liang M, Zhou P, Wang X, Zhang L (2015) Comprehensive analysis of antibody recognition in convalescent humans from highly pathogenic avian influenza H5N1 infection. Nat Commun 6: 8855-8867. doi: 10.1038/ncomms9855.
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.